Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 2/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 1.00 |
| ▸ | CCNA2 | P20248 | 1/20 | 1.00 |
| ▸ | CDK2 | P24941 | 1/20 | 1.00 |
| ▸ | MAPK14 | Q16539 | 1/20 | 1.00 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.97 |
| ▸ | SNCA | P37840 | 3/20 | 0.67 |
| ▸ | CHAT | P28329 | 1/20 | 0.67 |
| ▸ | FABP1 | P07148 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | NSD2 | O96028 | 2/20 | 0.51 |
| ▸ | CASP6 | P55212 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43158 | 1.00 | FABP4 (1.00) | FABP4TTRCCNA2CDK2MAPK14 | |
| Ammonia Solution, Strong SCHEMBL592279 | 0.98 | NR4A1 (1.00) | FABP4TTRCCNA2CDK2MAPK14 | |
| Ammonia Solution, Strong SCHEMBL592280 | 0.98 | NR4A1 (1.00) | FABP4TTRCCNA2CDK2MAPK14 | |
| SCHEMBL6654772 | 0.98 | FABP4 (0.97) | FABP4TTRCCNA2CDK2MAPK14 | |
| SCHEMBL10353163 | 0.98 | FABP4 (0.97) | FABP4TTRCCNA2CDK2MAPK14 | |
| SCHEMBL1786500 | 0.98 | FABP4 (0.97) | FABP4TTRCCNA2CDK2MAPK14 | |
| Ammonia Solution, Strong SCHEMBL31666356 | 0.97 | NR4A1 (0.97) | FABP4TTRCCNA2CDK2MAPK14 | |
| SCHEMBL7522280 | 0.92 | FABP4 (0.84) | FABP4TTRCCNA2CDK2MAPK14 | |
| SCHEMBL29837420 | 0.92 | CDK2 (0.84) | FABP4TTRCCNA2CDK2MAPK14 | |
| Questiomycin B SCHEMBL20817145 | 0.88 | TTR (0.78) | FABP4TTRCCNA2CDK2MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102332-A1 | NERVE AND TUMOR HOMING AGENTS AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4694868-A1 | PROTEIN PARTICLES AND METHODS OF MAKING AND USING THE SAME | Dairy Management Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4586911-A1 | LUMINESCENT ENZYME-BASED SENSORS | Terumo Cardiovascular Systems Corporation (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2025123135-A1 | ASSAY FOR DETECTION AND QUANTIFICATION OF PFAS COMPOUNDS | FREDSENSE TECHNOLOGIES CORP. (CA) | 2025-06-19 | — | — | WO | claimed |
| EP-4536933-A1 | FLUORESCENT METAL-ORGANIC FRAMEWORKS | Saudi Arabian Oil Company (SA) | 2025-04-16 | — | — | EP | claimed |
| WO-2024216002-A1 | PROTEIN PARTICLES AND METHODS OF MAKING AND USING THE SAME | Dairy Management Inc. (US) | 2024-10-17 | — | — | WO | claimed |
| EP-4427033-A1 | METHOD FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA Biotech GmbH (DE) | 2024-09-11 | — | — | EP | claimed |
| CN-117969472-A | Method for high-throughput determination of heat stability and iron saturation of lactoferrin | 陕西科技大学 | 2024-05-03 | — | — | CN | claimed |
| WO-2024059143-A1 | LUMINESCENT ENZYME-BASED SENSORS | TERUMO CARDIOVASCULAR SYSTEMS CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| WO-2023239252-A1 | FLUORESCENT METAL-ORGANIC FRAMEWORKS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-12-14 | — | — | WO | claimed |
| WO-2023079052-A1 | METHOD FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF PROTEIN AGGREGATES | PAIA BIOTECH GMBH (DE) | 2023-05-11 | — | — | WO | claimed |
| EP-4076500-A1 | METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS | Blaze Bioscience, Inc. (US) | 2022-10-26 | — | — | EP | claimed |
| EP-3948262-A1 | METHODS OF MEASURING HYDROPHOBICITY OF CHROMATOGRAPHIC RESINS | Bristol-Myers Squibb Company (US) | 2022-02-09 | — | — | EP | claimed |
| EP-4747264-A1 | MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE | University of Reading (GB) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026105126-A1 | DNA-BASED MECHANOSENSITIVE DELIVERY AGENTS AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026102332-A1 | NERVE AND TUMOR HOMING AGENTS AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-11278556-B2 | Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs | NATIONAL JEWISH HEALTH (US) | 2022-03-22 | — | — | US | disclosed |
| EP-3947438-A1 | STABILIZED MHC I | imusyn GmbH & Co. KG (DE) | 2022-02-09 | — | — | EP | disclosed |
| EP-3946256-A1 | HUMAN PAPILLOMAVIRUS NANOPARTICLE FORMULATIONS | Aura Biosciences, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-3948262-A1 | METHODS OF MEASURING HYDROPHOBICITY OF CHROMATOGRAPHIC RESINS | Bristol-Myers Squibb Company (US) | 2022-02-09 | — | — | EP | disclosed |